Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-18-021234

Chief Financial Officer sold 120 shares at $8.25 ($990)

  • Chief Financial Officer acquired 120 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BLOCH KATHLEEN P. · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-04-17 Exercise or conversion : show line 1 in the form +120 $4.69 $563 253,424 D
2018-04-17 Sale : show line 2 in the form −120 $8.25 $990 253,304 D
Open-market sales · 120 sh · avg $8.25 · $990

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-04-17 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −120 24,800 D
Loading xslF345X03/tv491396_4.xml…